eCite Digital Repository
Drug safety in Nigeria
Citation
Yakubu, R and Isa, AM and Jatau Abubakar, I and Oreagba, I and Awaisu, A, Drug safety in Nigeria, Drug Safety in Developing Countries: Achievements and Challenges, Academic Press, Y Al-Worafi (ed), United Kingdom, pp. 525-556. ISBN 978-0-12-819837-7 (2020) [Research Book Chapter]
Copyright Statement
Copyright 2020 Elsevier Inc.
DOI: doi:10.1016/B978-0-12-819837-7.00038-8
Abstract
Ensuring the effectiveness and safety of drug therapy is a critical component of the mission of pharmacy practice. The mission
promotes delivery of pharmaceutical care to contribute to improvement of health and helping patients make the best
use of their medicines (WHO, 2011b). To emphasize the importance of drug safety, the World Health Organization (WHO)
has developed tools to help families, patients, and caregivers greatly reduce the risks of harm associated with the use of
their medication. (WHO, 2019b) As part of its global commitment to safety in health, the WHO declares every September
17, from 2019 onward as World Patient Safety Day to showcase commitments by all stakeholders in health care systems to
the safety of the patient. This becomes pertinent with the revelation of 134 million adverse events occurring on an annual
basis due to unsafe care in low- and middle-income countries, resulting in 2.6 million deaths (IAPO, 2019).
The patient safety, of which drug safety is a cornerstone, is a growing public health concern. Recognizing this challenge,
the 72nd World Health Assembly passed a resolution in May 2019 known as resolution WHA72.6 (Global action on patient
safety) (WHO, 2019a) The resolution demands global concerted effort from 194 member countries to commit to safety in
health care thereby minimizing avoidable harm in health care systems, which could help to accelerate the achievement of
Universal Health Coverage (IAPO, 2019). With the current WHO initiatives targeted to safeguard the lives of patients
through safety in health care, evaluating drug safety in Nigeria to determine challenges and offer recommendations is a step
in the right direction. This chapter, therefore, is primarily intended to explore the status of drug safety issues in Nigeria.
Item Details
Item Type: | Research Book Chapter |
---|---|
Keywords: | drug safety, Nigeria, drug abuse |
Research Division: | Biomedical and Clinical Sciences |
Research Group: | Pharmacology and pharmaceutical sciences |
Research Field: | Toxicology (incl. clinical toxicology) |
Objective Division: | Expanding Knowledge |
Objective Group: | Expanding knowledge |
Objective Field: | Expanding knowledge in the health sciences |
UTAS Author: | Jatau Abubakar, I (Mr Ibrahim Jatau Abubakar) |
ID Code: | 139879 |
Year Published: | 2020 |
Deposited By: | Pharmacy |
Deposited On: | 2020-07-10 |
Last Modified: | 2021-07-06 |
Downloads: | 0 |
Repository Staff Only: item control page